KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) has very high prevalence and associated-mortality. However, targeted therapies that are currently used in clinical practice for HCC have certain limitations, in part because of the lack of reliable and clinically applicable biomarkers that can be used for d...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Shi, Lei, Zhang, Wenfa, Zou, Fagui, Mei, Lihua, Wu, Gang, Teng, Yong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073891/
https://ncbi.nlm.nih.gov/pubmed/27769251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2851-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller